Skip to content

EBIT at other companies

LivaNova logo
LivaNovaLIVN
$41.47M-14.7%
ITG
Integer HoldingsITGR
$31.87M-35.7%
Stryker logo
StrykerSYK
Medtronic logo
MedtronicMDT
Intuitive Surgical logo
Intuitive SurgicalISRG

Other financials

Income statement

See full
Revenue$204.6M+1.6%
Gross profit$176.9M+3.7%
Operating income-$1.1M+24.7%
Net income-$11.3M-477%
EPS (diluted)-$0.39-490%

Balance sheet

See full
Cash & equivalents$98.9M+83.6%
Total debt$29.6M-11.8%
Total equity$792.3M+24.6%
Total assets$911.4M+24.7%

Cash flow

See full
Operating cash flow$12.8M+292%
CapEx$9.7M+15.7%
Free cash flow$3.1M+121%

Valuation

See full
Market cap$1.24B-67.8%
Enterprise value$1.18B-69.4%
P/E9.5×-48.6×
P/S1.4×-3.2×

Profitability

See full
Gross margin85.8%+1.1pp
Operating margin5.6%-0.3pp
Net margin14.3%+6.4pp
FCF margin10.6%+1.2pp

Returns & leverage

See full
Return on equity18.4%+7.5pp
Debt / equity0.0×
Current ratio6.3×-2.7×

Where this comes from

Calculated from Inspire Medical Systems’s reported figures.

Plus components not separately reported this period.

The official record: Inspire Medical Systems’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Inspire Medical Systems's ebit.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Inspire Medical Systems's EBIT?
Inspire Medical Systems (INSP) reported EBIT of -$1.12M in Q1 2026.
How has Inspire Medical Systems's EBIT changed year-over-year?
Inspire Medical Systems's EBIT increased by 24.7% year-over-year, from -$1.49M to -$1.12M.
What is the long-term trend for Inspire Medical Systems's EBIT?
Over 3 years (2021 to 2025), Inspire Medical Systems's EBIT has grown at a 8.5% compound annual growth rate (CAGR), from -$39.85M to $50.95M.
What does EBIT mean?
Earnings before interest and taxes — the profit from the business before financing cost and tax. Uses reported operating income where a company reports it; otherwise pre-tax income plus interest expense. Lets companies be compared on earning power independent of capital structure.